January 29, 2015 6:20 AM ET


Company Overview of InCarda Therapeutics, Inc.

Company Overview

InCarda Therapeutics, Inc. develops transformative therapies that enable patients to use in the first moments of acute cardiovascular symptoms. The company develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. InCarda Therapeutics, Inc. was formerly known as Pleiades Cardio-Therapeutics, Inc. The company was incorporated in 2009 and is based in San Francisco, California.

150 Post Street

Suite 650

San Francisco, CA 94108

United States

Founded in 2009





Key Executives for InCarda Therapeutics, Inc.

Co-Founder and Executive Chairman
Age: 66
Co-Founder and Chief Operating Officer
Co-Founder and Chief Scientific Officer
Co-Founder and Chief Medical Officer for Consulting
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Corceuticals, LLC United States
Averion Lifesciences Staffing Solutions United States
Bioserv Corporation United States
Tosk, Inc. United States
Secretory IgA, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact InCarda Therapeutics, Inc., please visit incardatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.